Skip to main content
Premium Trial:

Request an Annual Quote

JCVI to Use Pressure Bio's Sample Prep Technology in Microbiome Study

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that it has entered into a collaboration with the J. Craig Venter Institute, under which JVCI has purchased one of the firm’s Barocycler NEP2320 PCT Sample Preparation Systems.
 
JVCI will use the system, which incorporates the firm’s pressure cycling technology, for its research as part of the NIH-funded Human Microbiome Project. Pressure Bio also intends to provide JCVI with two more instruments for additional studies as part of the collaboration.
 
In addition to using the instruments, JCVI will further develop the pressure cycling technology into its extraction protocols.
 
The technology is used for extracting nucleic acids and proteins from samples, and Scott Peterson, director of functional genomics research and technology at JCVI, said that it has “the unique ability to extract higher molecular weight DNA for further sequence analysis of the organisms we work with here at JCVI.”
 
South Easton, Mass.-based Pressure Bio also said that it has sold two PCT Sample Preparation Systems to an unnamed global pharmaceutical company.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.